Chidamide improves gefitinib treatment outcomes in NSCLC by attenuating recruitment and immunosuppressive function of myeloid-derived suppressor cells

Autor: Shao, Jinjin, Ye, Zhichao, Shen, Zeren, Liu, Nienwei, Zhang, Lijiang, Tachibana, Masashi, Xie, Zhiqi
Zdroj: In Biomedicine & Pharmacotherapy April 2024 173
Databáze: ScienceDirect